Clinical Trials on Female Pattern Alopecia

Total 21487 results

Venus Concept

Recruiting

Computer-Assisted Hair Restoration Study Using ARTAS System

Androgenic Alopecia

United States
Icahn School of Medicine at Mount Sinai

Not yet recruiting

Dupilumab in the Treatment of Pediatric Alopecia Areata (PEDAL)

Alopecia Areata

United States
ASLAN Pharmaceuticals

Recruiting

Investigate the Efficacy and Safety of Farudodstat Compared With Its Placebo in Adult Alopecia Areata Participants (FAST-AA)

Alopecia Areata

United States
Assiut University

Not yet recruiting

Topical Cetirizine in Treatment of Localized Alopecia Areata

Alopecia Areata
Assiut University

Not yet recruiting

Role of Minoxidil in Alopecia Areata Transepidermal Drug Delivery of Minoxidil Via Either Fractional Carbon Dioxide Laser or Microneedling Versus Its Topical Nanoparticles Preparation for Treatment of Alopecia Areata

Alopecia Areata
Emma Guttman
Regeneron Pharmaceuticals

Recruiting

Regeneron AA Multicenter (Dupilumab)

Alopecia Areata

United States
Sichuan Kelun Pharmaceutical Research Institute...

Not yet recruiting

A Study of KL130008 in Adults With Severe Alopecia Areata

Alopecia Areata

China
AnaptysBio, Inc.

Recruiting

A Study to Evaluate the Efficacy and Safety of Rosnilimab (ANB030) in Treatment of Subjects With Moderate-to-Severe Alopecia Areata (AZURE)

Alopecia Areata

United States
Assiut University

Not yet recruiting

Excimer Light and Topical Steroid in Treatment of Alopecia Areata

Alopecia Areata
Eli Lilly and Company
Incyte Corporation

Active, not recruiting

A Study of Baricitinib (LY3009104) in Participants With Severe or Very Severe Alopecia Areata (BRAVE-AA1)

Alopecia Areata

United States, Japan, Puerto Rico, Mexico, Korea, Republic of
Eurofarma Laboratorios S.A.

Active, not recruiting

Treatment of Androgenetic Alopecia in Men for 24 Weeks (MINOX)

Alopecia

Brazil
Q32 Bio Inc.
Innovaderm Research Inc.

Active, not recruiting

Randomized, Double-Blind, Placebo-Controlled Phase 2a, Proof-of-Concept Trial of ADX-914 Phase 2a Trial for the Treatment of Severe Alopecia Areata (SIGNAL-AA)

Alopecia Areata

United States
Concert Pharmaceuticals

Completed

A Study to Evaluate the Durability of Response Study of CTP-543 in Adult Patients With Moderate to Severe Alopecia Areata

Alopecia Areata

United States
Ornovi, Inc.

Withdrawn

A First in Human Single and Multiple Ascending Dose and Open Label Food Effect Study of OR-101 in Healthy Subjects

Alopecia Areata

Australia
Egymedicalpedia

Completed

Evaluation of the Effect of Topical Calcipotriol Versus Platelet-Rich Plasma

Alopecia Areata

Egypt
Pfizer
Arena is a wholly owned subsidiary of Pfizer

Completed

Safety and Efficacy of Oral Etrasimod in Adult Participants With Moderate-to-Severe Alopecia Areata

Alopecia Areata

United States, Canada
Concert Pharmaceuticals

Completed

Study to Evaluate the Efficacy and Safety of CTP-543 in Adults With Moderate to Severe Alopecia Areata (THRIVE-AA2) (THRIVE-AA2)

Alopecia Areata

Spain, United States, Poland, Canada, France, Germany, Hungary
Concert Pharmaceuticals

Completed

Study to Evaluate the Efficacy and Safety of CTP-543 in Adults With Moderate to Severe Alopecia Areata (THRIVE-AA1) (THRIVE-AA1)

Alopecia Areata

United States, Canada, Poland, France, Spain
Yale University

Completed

Follicular Revival in Treatment-resistant Alopecia Areata: Evaluating Use of Micro-needling

Alopecia Areata

United States
Suzhou Zelgen Biopharmaceuticals Co.,Ltd

Completed

Study to Evaluate the Safety and Efficacy ofJaktinib Hydrochloride Tablets in Severe Alopecia Areata

Alopecia Areata

China
Bioithas SL
Bionou Research, S.L.

Completed

Clinical Trial to Evaluate Effectiveness of a Probiotic Preparation Administered to Patients With Alopecia Areata

Alopecia Areata

Spain
Centre Hospitalier Universitaire de Nice

Terminated

Evaluation of the Efficacy and Tolerability of Treatment With Interleukin-2 in Severe and Resistant Alopecia Areata (IL2)

Alopecia Areata

France
Tufts Medical Center
Pfizer

Withdrawn

Topical Crisaborole in Patients With Alopecia Areata

Alopecia Areata

United States
Icahn School of Medicine at Mount Sinai
Novartis

Terminated

A Study of Secukinumab for the Treatment of Alopecia Areata

Alopecia Areata

United States
University of Minnesota

Completed

Combined Restylane and Triamcinolone Acetonide Injections for the Treatment of Alopecia Areata

Alopecia Areata

United States
Legacy Healthcare SA

Completed

Efficacy, Safety and Tolerability of CG428 Cutaneous Solution on Chemotherapy Induced Alopecia; Controlled Study (ELAN) (ELAN)

Alopecia

Switzerland
Columbia University
University of Minnesota

Terminated

Intralesional Steroids in the Treatment of Alopecia Areata

Alopecia Areata

United States
Columbia University
Locks of Love

Completed

Study To Evaluate The Efficacy Of Tofacitinib In Moderate To Severe Alopecia Areata, Totalis And Universalis

Alopecia Areata

United States
Allergan

Completed

A Safety and Efficacy Study of Setipiprant Tablets in Androgenetic Alopecia in Males

Alopecia

United States
Aswan University Hospital

Completed

Topical Calcipotriol Versus Narrowband Ultraviolet B in Treatment of Alopecia Areata

Alopecia Areata

Egypt
University of Florida

Completed

Point-of-Care Adipose-derived Cells for Hair Growth (ASVF-2016)

Androgenetic Alopecia

United States
GlaxoSmithKline

Completed

A Study To Assess The Efficacy And Safety Of Dutasteride 0.5mg Once Daily For 6 Months In The Treatment Of Male Subjects With Androgenetic Alopecia

Alopecia
Postgraduate Institute of Medical Education and...

Completed

Comparison of Topical Latanoprost vs Topical Corticosteroid in Treatment of Localized Alopecia Areata (COLA)

Alopecia Areata

India
University of British Columbia

Unknown

Excimer Light for Alopecia Areata

Alopecia Areata

Canada
University of British Columbia

Completed

The Efficacy and Safety of Different Concentrations of Localized Injections of Steroids in the Treatment of Alopecia Areata

Alopecia Areata

Canada
Columbia University

Withdrawn

A Clinical Trial to Evaluate the Efficacy of Abatacept in Moderate to Severe Alopecia Areata

Alopecia Areata

United States
University of California, San Francisco

Completed

Efficacy Study of Latanoprost and Bimatoprost Solutions in Promoting Eyelash Growth in Patients With Alopecia Areata

Alopecia Areata

United States
Hamamatsu University

Unknown

The Effect of 0.5% Roxithromycin Lotion for Androgenetic Alopecia

Alopecia

Japan
Sheba Medical Center

Unknown

Comparative Study Examining the Effectiveness in Use of a DERMOJET and a Normal Syringe Treatment for Patients With Hair Loss - Alopecia Areata

Alopecia Areata

Israel
Hordinsky, Maria K., MD
3M; National Alopecia Areata Foundation

Completed

Aldara for the Treatment of Extensive Alopecia Areata

Alopecia Areata

United States
Memorial Sloan Kettering Cancer Center

Active, not recruiting

A Study of PRP Treatment for Hair Loss After Cancer Therapy in Women With Breast Cancer

Alopecia

United States
Icahn School of Medicine at Mount Sinai

Terminated

Efficacy of Hair Transplantation Compared With Hypodermic Needle Irritation in Alopecia Areata

Alopecia | Alopecia Areata | Balding

United States
Second Affiliated Hospital, School of Medicine,...

Recruiting

The Metabolic Characteristics in Sublobar Areas of PRE Based on FDG-PET Study

Interictal FDG-PET Hypometabolism Patterns

China
QinetiQ Ltd
Ministry of Defence, United Kingdom

Completed

Effect of Fasting Versus Feeding on the Bone Metabolic Response to Running

Bone Resorption | Feeding Patterns

United Kingdom
Cutia Therapeutics（Wuxi）Co.,Ltd

Recruiting

A Phase I Clinical Trial Evaluating the Safety, Tolerability, and Pharmacokinetics of CU-40101 Liniment in Single and Multiple Doses in Adult Male Androgenic Alopecia Subjects

AGA

China
Cutia Therapeutics（Wuxi）Co.,Ltd

Completed

A Phase 3 Clinical Study Patients With Androgenetic Alopecia (AGA)

AGA

China
Integrative Skin Science and Research
Vidya Herbs (Sponsor)

Recruiting

The Effects of an Oral Hair Supplement on Hair Density, Growth, and Microbiome

Hair Thinning

United States
Pfizer
In Expanded Access, treating physicians are the Sponsors

Available

Pre-approval Single-patient Expanded Access for Ritlecitinib (PF-06651600)

Alopecia Areata
Emma Guttman

Completed

A Pilot Study of Tralokinumab in Subjects With Moderate to Severe Alopecia Areata

Alopecia Areata

United States
Ablon Skin Institute Research Center
Nutraceutical Wellness Inc.

Completed

Efficacy and Safety of a Nutraceutical Supplement With Standardized Botanicals in Women With Thinning Hair

Hair Thinning

United States

3

Subscribe